Thinking of joining a study?

Register your interest

NCT04335773 | RECRUITING | Pediatric Respiratory Diseases


COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology
Sponsor:

University Hospital, Akershus

Information provided by (Responsible Party):

Christopher Inchley

Brief Summary:

Prospective cohort study of COVID-19 infection among children in Norway.

Condition or disease

Pediatric Respiratory Diseases

COVID

Fatigue Post Viral

Detailed Description:

This nation-wide, prospective cohort study of COVID-19 infection addresses three main issues: 1) Epidemiological risk factors; 2) Natural history (including immunological mechanisms and long term effects) and 3) Support of infection prevention. Also, the study focuses solely on children. Children (0-18 years of age) admitted to hospital with suspected COVID-19 are eligible (Fig. 1). Those with confirmed COVID-19 serve as cases, whereas those with non-COVID-19 serve as controls; both groups will be followed prospectively for 6 months. Three objectives/Work Packages (WPs) are defined: * In WP1, the investigators will investigate risk factors for severe outcome of the acute infection; potential risk factors include sex, age, comorbidities, initial clinical findings, infectious load, and genetic markers. * In WP2, the investigators will investigate the immunological response to acute infection, focusing on initial innate host response and its associations to inflammatory enhancement, genetic factors and clinical course. * In WP3, the investigators will investigate the prevalence and risk factors of long-lasting complication, in particular the development of post-infectious chronic fatigue

Study Type : OBSERVATIONAL
Estimated Enrollment : 350 participants
Official Title : COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology
Actual Study Start Date : 2020-04-03
Estimated Primary Completion Date : 2030-12-31
Estimated Study Completion Date : 2030-12-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: to 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • Suspected covid-19 infection and age 0-18 years
Exclusion Criteria
  • Age \>18 years

COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology

Location Details

NCT04335773


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

Norway,

Akershus University Hospital

Lørenskog, Norway,

Loading...